Physician profile
Christopher Wood
NPI 1528351954
$1,492.93
in general payments reported to CMS, 2019-2025
16 companies · $95.45 in 2025
The $95.45 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $150 · 2021: $37.28 · 2022: $232 · 2023: $518 · 2024: $184 · 2025: $95.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $511.15 | 2019-2025 | Rinvoq, Skyrizi |
| Boston Scientific Corporation | $162.20 | 2020-2024 | |
| Janssen Biotech, INC. | $148.19 | 2019-2024 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $144.24 | 2019-2024 | Entyvio, Gattex |
| Celgene Corporation | $118.01 | 2023-2024 | Zeposia |
| Gilead Sciences, INC. | $93.11 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.35 | 2020-2023 | Plenvu, Xifaxan |
| Genzyme Corporation | $57.10 | 2022-2023 | |
| Braintree Laboratories, INC. | $41.48 | 2022 | |
| Pentax of America, INC. | $35.31 | 2023 | |
| Exact Sciences Corporation | $31.09 | 2023 | Cologuard Collection Kit |
| Fresenius Kabi USA, LLC | $27.76 | 2023 | |
| Allergan, INC. | $25.09 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.61 | 2019 | |
| Covidien Lp | $13.51 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $12.73 | 2023 | Erbe |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.